A microfluidic platform for the characterisation of CNS active compounds

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

New in vitro technologies that assess neuronal excitability and the derived synaptic activity within a controlled microenvironment would be beneficial for the characterisation of compounds proposed to affect central nervous system (CNS) function. Here, a microfluidic system with computer controlled compound perfusion is presented that offers a novel methodology for the pharmacological profiling of CNS acting compounds based on calcium imaging readouts. Using this system, multiple applications of the excitatory amino acid glutamate (10 nM - 1 mM) elicited reproducible and reversible transient increases in intracellular calcium, allowing the generation of a concentration response curve. In addition, the system allows pharmacological investigations to be performed as evidenced by application of glutamatergic receptor antagonists, reversibly inhibiting glutamateinduced increases in intracellular calcium. Importantly, repeated glutamate applications elicited significant increases in the synaptically driven activation of the adjacent, environmentally isolated neuronal network. Therefore, the proposed new methodology will enable neuropharmacological analysis of CNS active compounds whilst simultaneously determining their effect on synaptic connectivity.
LanguageEnglish
Number of pages18
JournalScientific Reports
Early online date16 Nov 2017
DOIs
Publication statusE-pub ahead of print - 16 Nov 2017

Fingerprint

Microfluidics
Neurology
Calcium
Central Nervous System
Glutamic Acid
Pharmacology
Excitatory Amino Acids
Computer Systems
Amino acids
Perfusion
Chemical activation
Technology
Imaging techniques

Keywords

  • microfluidic perfusion
  • pharmacology
  • calcium imaging
  • synaptic activity assay

Cite this

@article{d604fdd3656a43eabd1122634aaae73f,
title = "A microfluidic platform for the characterisation of CNS active compounds",
abstract = "New in vitro technologies that assess neuronal excitability and the derived synaptic activity within a controlled microenvironment would be beneficial for the characterisation of compounds proposed to affect central nervous system (CNS) function. Here, a microfluidic system with computer controlled compound perfusion is presented that offers a novel methodology for the pharmacological profiling of CNS acting compounds based on calcium imaging readouts. Using this system, multiple applications of the excitatory amino acid glutamate (10 nM - 1 mM) elicited reproducible and reversible transient increases in intracellular calcium, allowing the generation of a concentration response curve. In addition, the system allows pharmacological investigations to be performed as evidenced by application of glutamatergic receptor antagonists, reversibly inhibiting glutamateinduced increases in intracellular calcium. Importantly, repeated glutamate applications elicited significant increases in the synaptically driven activation of the adjacent, environmentally isolated neuronal network. Therefore, the proposed new methodology will enable neuropharmacological analysis of CNS active compounds whilst simultaneously determining their effect on synaptic connectivity.",
keywords = "microfluidic perfusion, pharmacology, calcium imaging, synaptic activity assay",
author = "Christopher MacKerron and Graham Robertson and Michele Zagnoni and Trevor Bushell",
year = "2017",
month = "11",
day = "16",
doi = "10.1038/s41598-017-15950-0",
language = "English",
journal = "Scientific Reports",
issn = "2045-2322",

}

TY - JOUR

T1 - A microfluidic platform for the characterisation of CNS active compounds

AU - MacKerron, Christopher

AU - Robertson, Graham

AU - Zagnoni, Michele

AU - Bushell, Trevor

PY - 2017/11/16

Y1 - 2017/11/16

N2 - New in vitro technologies that assess neuronal excitability and the derived synaptic activity within a controlled microenvironment would be beneficial for the characterisation of compounds proposed to affect central nervous system (CNS) function. Here, a microfluidic system with computer controlled compound perfusion is presented that offers a novel methodology for the pharmacological profiling of CNS acting compounds based on calcium imaging readouts. Using this system, multiple applications of the excitatory amino acid glutamate (10 nM - 1 mM) elicited reproducible and reversible transient increases in intracellular calcium, allowing the generation of a concentration response curve. In addition, the system allows pharmacological investigations to be performed as evidenced by application of glutamatergic receptor antagonists, reversibly inhibiting glutamateinduced increases in intracellular calcium. Importantly, repeated glutamate applications elicited significant increases in the synaptically driven activation of the adjacent, environmentally isolated neuronal network. Therefore, the proposed new methodology will enable neuropharmacological analysis of CNS active compounds whilst simultaneously determining their effect on synaptic connectivity.

AB - New in vitro technologies that assess neuronal excitability and the derived synaptic activity within a controlled microenvironment would be beneficial for the characterisation of compounds proposed to affect central nervous system (CNS) function. Here, a microfluidic system with computer controlled compound perfusion is presented that offers a novel methodology for the pharmacological profiling of CNS acting compounds based on calcium imaging readouts. Using this system, multiple applications of the excitatory amino acid glutamate (10 nM - 1 mM) elicited reproducible and reversible transient increases in intracellular calcium, allowing the generation of a concentration response curve. In addition, the system allows pharmacological investigations to be performed as evidenced by application of glutamatergic receptor antagonists, reversibly inhibiting glutamateinduced increases in intracellular calcium. Importantly, repeated glutamate applications elicited significant increases in the synaptically driven activation of the adjacent, environmentally isolated neuronal network. Therefore, the proposed new methodology will enable neuropharmacological analysis of CNS active compounds whilst simultaneously determining their effect on synaptic connectivity.

KW - microfluidic perfusion

KW - pharmacology

KW - calcium imaging

KW - synaptic activity assay

UR - https://www.nature.com/srep/

U2 - 10.1038/s41598-017-15950-0

DO - 10.1038/s41598-017-15950-0

M3 - Article

JO - Scientific Reports

T2 - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

ER -